By Product
- SVF Aspiration Products
- SVF Transfer Products
- SVF Isolation Products
By Application
- Cosmetic Applications
- Orthopedic Applications
- Soft Tissue Applications
- Others
By End User
- Hospitals
- Specialty Clinics
- Stem Cell Banks/ Laboratories
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market is categorised into product, application, end user and region. The product segment is classified into SVF aspiration products, SCF transfer products, SVF isolation products. The SVF isolation products segment is further divided into enzymatic isolation products, non-enzymatic isolation products, automated POC devices. The application segment is fragmented into cosmetic applications, orthopedic applications, soft tissue applications and others. The end user segment is diversified into hospitals, specialty clinics, stem cell banks and others.
The North America region is expected to hold the largest stromal vascular fraction market share owing to the rising prevalence of musculoskeletal disorders like osteoarthritis, growing awareness pertaining to stem cell therapy, soaring number of cosmetic surgeries along with growing insistence from clinicians. Furthermore, the increasing investments in research and development of novel technologies coupled with the escalating number of private hospitals across the region.